sufentanil has been researched along with Crohn Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Hoore, A; Fieuws, S; Penninckx, F; Wolthuis, AM | 1 |
Colombel, JF; Desreumaux, P; Fleyfel, M; Gambiez, L; Guidat, A; Levron, JC; Scherpereel, P; Vallet, B | 1 |
1 trial(s) available for sufentanil and Crohn Disease
Article | Year |
---|---|
Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Area Under Curve; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Glycoproteins; Humans; Inflammation; Male; Prospective Studies; Reference Values; Sufentanil; Time Factors | 2003 |
1 other study(ies) available for sufentanil and Crohn Disease
Article | Year |
---|---|
Outcomes for case-matched single-port colectomy are comparable with conventional laparoscopic colectomy.
Topics: Adenoma; Adult; Aged; Analgesics; Blood Loss, Surgical; Bupivacaine; C-Reactive Protein; Colectomy; Colonic Neoplasms; Crohn Disease; Diverticulitis, Colonic; Female; Humans; Laparoscopy; Length of Stay; Levobupivacaine; Male; Middle Aged; Pain, Postoperative; Statistics, Nonparametric; Sufentanil; Time Factors; Treatment Outcome | 2012 |